中西医结合治疗慢性盆腔炎临床疗效及机理探讨

来源 :深圳中西医结合杂志 | 被引量 : 0次 | 上传用户:flyingmomo1986
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:观察中西医结合方法治疗慢性盆腔炎的临床效果及其对细胞因子的影响。方法:将符合诊断标准的患者随机分为观察组(30例)和对照组(32例),分别采用化瘀止痛利湿中药内服、灌肠和单纯应用西药治疗,观察两组的近期临床疗效,细胞因子IL–2、IL–10等指标的变化情况。结果:观察组和对照组的总有效率分别为93.33%和71.89%,两组相比差异有统计学意义(P<0.05);两组治疗后升高患者的IL–2,IL–10,但观察组的上述作用显著优于对照组(P<0.05)。结论:化瘀止痛利湿中药内服、灌肠配合抗菌素治疗慢性盆腔炎的综合作用优于单纯使用抗菌素,其治疗机制可能与抗炎和免疫调节有关。 Objective: To observe the clinical efficacy of traditional Chinese and western medicine in the treatment of chronic pelvic inflammatory disease and its effect on cytokines. Methods: The patients who met the diagnostic criteria were randomly divided into observation group (n = 30) and control group (n = 32). The patients were treated with Huayu Zhitong Lishi Chinese herbs orally, enema and western medicine alone. The curative effect, Cytokines IL-2, IL-10 and other indicators of changes. Results: The total effective rate of the observation group and the control group were 93.33% and 71.89% respectively, there was significant difference between the two groups (P <0.05). The IL-2, IL-10, However, the above-mentioned effects of the observation group were significantly better than those of the control group (P <0.05). Conclusion: The comprehensive effects of Huayu Zhitonglixu Chinese herbal medicine and enema combined with antibiotics in treating chronic pelvic inflammatory disease are better than that of simply using antibiotics. The therapeutic mechanism may be related to anti-inflammation and immune regulation.
其他文献
近日。中石化青岛大炼油项目将于2008年初投产的消息不胫而走。而另一石油巨头中石油集团下的广西千万吨级炼油项目到2007年底也已完成投资22亿多元,预计2008年年底前起可陆续投产。此外。第三大石油公司中海油总公司旗下的惠州年产1200万吨炼油项目也有望于2008年6月完成装置试车。由此,中国三大石油集团的三个千万吨级炼油项目均有望在2008年投产,全部建成后新增的成品油供应能力高达2000万吨以
近年来,高考的利弊、存废都成为社会各界讨论的热点话题。我国高考制度改革虽然措施不断,高考制度的弊端却日益凸显,这在很大程度上对基础教育的发展带来了负面影响。致力于
期刊